Table of Contents
Description
Priority Announcements on CIHR Operating Grant competitions offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the March 2008 (2008-03) competition of the Operating Grant: 2007-2008 funding opportunity.
The Operating Grant Program is the foundation of CIHR's programming. CIHR recognizes that the creativity, skill, and insight of individuals and self-assembled teams lie at the heart of the research enterprise. The pursuit of excellence in research, as evaluated through the peer review process, inspires ideas that drive progress and ensures a continuous flow of fresh insights.
Funds Available
CIHR's contribution to the amount available for these strategic initiatives is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.
Funds Available for Research in All Areas:
Funds are available for applications in all areas of research that address any important health problem or issue through the March 2008 (2008-03) competition of the CIHR Operating Grant: 2007-2008 funding opportunity.
Funds Available for Research in Specific Areas:
In this competition, funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded as well as the maximum amounts per grant that can be requested is found in the "Objectives" section.
A. CIHR Research Priority Areas:
- Aging
- Blood Supply Risk
- Blood Utilization and Conservation
- Ethics
- History of Medicine
- HIV/AIDS
- Infrastructure and Operating Grants (Leaders Opportunity Fund)
- Musculoskeletal Health, Arthritis, Skin and Oral Health
- Neuromuscular Research (Neuromuscular Partnership Program
- Obesity and Healthy Body Weight
- Official Language minority Communities
- Pandemic Preparedness
- Parkinson (Parkinson Society Canada/CIHR-INMHA Research Grant)
- Regional Partnerships Program - Manitoba (RPP-MB)
- Regional Partnerships Program - New Brunswick (RPP-NB)
- Regional Partnerships Program - Newfoundland and Labrador (RPP-NL)
- Regional Partnerships Program - Nova Scotia (RPP-NS)
- Regional Partnerships Program - Prince Edward Island (RPP-PEI)
- Regional Partnerships Program - Saskatchewan (RPP-SK)
- Reproductive and Child Health (Start-Up Grants)
- Transfusion related acute lung injury (TRALI)
B. Research Related to CIHR Institute Mandates:
- Institute of Cancer Research
- Institute of Circulatory and Respiratory Health (Bridge Funding)
- Institute of Genetics (Bridge-Funding)
- Institute of Infection and Immunity (Bridge Funding)
- Institute of Neuroscience, Mental Health and Addiction (Bridge Funding)
- Institute of Nutrition, Metabolism and Diabetes (Bridge Funding)
Top
Objectives
The specific objective of the Operating Grant Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates.
CIHR Research Priority Areas:
1. Aging. The CIHR Institute of Aging will fund applications that are determined to be relevant to the research priority areas described below:
The maximum amount awarded for a single grant is up to $150,000 per annum for up to one year, for those applications within and across the Institute's priority topics, and up to three years, for those applications relevant to the Mobility in Aging Initiative. CIHR-IA anticipates that six grants will be funded through this competition.
Additional Information:
- CIHR-IA will evaluate for relevance using the following criteria which must be addressed in separate paragraphs within one relevance form (see "How to Apply"). You will be required to attach an additional one page document to your application to explain the relevance of your proposal to the research priorities. If you do not require the additional space for your explanation, please copy the information you have entered in the "relevance description" field onto an additional page and attach it to your application.
- Criterion #1: Extent to which the proposal addresses one or more of the five IA priority topics;
- Criterion #2: Extent to which the research and research design address issues of aging and/or the aged as essential elements of the research objectives, hypotheses and analyses (e.g., dynamics of aging, age-relevant models and/or aged subjects; uniqueness of aging or aged population).
- Criterion #3 (optional): Extent to which the proposal addresses eligible areas of inquiry under the Mobility in Aging Initiative.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
2. Blood Supply Risk. The CIHR Institute of Circulatory and Respiratory Health in partnership with Canadian Blood Services (CBS) will fund applications that are determined to be relevant to the research priority areas described below:
- Donor deferral strategies and the risk of transmission of blood bourne diseases
- Policy development and social aspects of blood system risk
- Emerging pathogens in specific populations including sexually active gay men
More information on the research priorities of CIHR-ICRH and Canadian Blood Services can be found on their websites.
Additional Information:
- Partner will not pay for parental leave but agrees to extend the term of the grant by the duration of the leave
- The grant is non-renewable
- The grant must be held in Canada
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
3. Blood Utilization and Conservation. The CIHR Institute of Circulatory and Respiratory Health in partnership with Canadian Blood Services (CBS) will fund applications that are determined to be relevant to the research priority areas described below:
- Blood Utilization and Conservation
More information on the research priorities of CIHR-ICRH and Canadian Blood Services can be found on their websites.
Additional Information:
- Partner will not pay for parental leave but agrees to extend the term of the grant by the duration of the leave
- The grant is non-renewable
- The grant must be held in Canada
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
4. Ethics. The CIHR Ethics Office will fund applications that are determined to be relevant to the research priorities described below:
- Research in ethics related to health, health research and/or health policy.
This funding opportunity is intended to support excellent applications for 1) research projects in ethics on any relevant research questions within the domains of biomedical sciences, clinical sciences, health services and policy, and population and public health; and 2) conceptual and/or empirical research addressing ethical challenges relevant to CIHR's mandate.
Ethics issues associated with health, health research or health policy must be the central focus of the proposed study, and may relate to ethics models, frameworks, concepts, principles or values, and/or the application of these. Scientific, social and legal issues, if addressed, should support the elucidation of the ethical issues.
The maximum amount awarded for a single grant is $50,000 per annum for up to three years. CIHR anticipates that one to three grants will be funded through this competition.
Additional Information:
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
5. History of Medicine. The Associated Medical Services (AMS) will contribute additional funds towards grants awarded in the history of medicine, as described below:
- History of medicine, health, health care or disease (broadly defined).
The goals of this collaboration include: to streamline administration of research funding in the history of medicine and health for both organizations; to develop capacity to conduct research in the history of medicine; and to broaden the understanding of how historical evidence can address contemporary health issues (e.g. epidemics like SARS, health care system reforms.)
More information on the research priorities of the Associated Medical Services can be found on their website.
The maximum amount awarded for a single grant is up to $25,000 per annum for up to five years. CIHR anticipates that approximately five additional grants will be funded through this competition.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
6. HIV/AIDS. The CIHR Institute of Infection and Immunity - HIV/AIDS Research Initiative will fund applications that are determined to be relevant to the research priority areas described below:
- Health systems, services and policy
- Resilience, vulnerability and determinants of health
- Prevention technologies and interventions
- Drug development, toxicities and resistance
- Pathogenesis
- Issues of co-infection
More information on the research priorities of the HIV/AIDS Research Initiative can be found on the Institute of Infection and Immunity website. Research in the priority areas described above that focuses on at risk populations including people living with HIV/AIDS, men who have sex with men, injection drug users, Aboriginal Peoples, prison inmates, youth at risk, women at risk and people from countries where HIV is endemic, is encouraged.
The maximum amount awarded for a single grant is $200,000 per annum for up to three years. CIHR anticipates that six grants will be funded through this competition.
Additional Information:
- The primary research focus of the application must be HIV/AIDS.
- Applications to the HIV/AIDS Research Initiative are sought in two distinct funding streams - Biomedical/Clinical Research and Health Services/Population Health Research. Although projects which display a multidisciplinary approach across all four research pillars are strongly encouraged and accepted, applicants must clearly indicate the most relevant funding stream in the relevance field of their ResearchNet application.
- The grant is non-renewable
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
7. Infrastructure and Operating Grants (Leaders Opportunity Fund). CIHR, in partnership with the Canada Foundation for Innovation (CFI)1, will fund applications that are determined to be relevant2 to the research priority area described below:
The objectives of this initiative are: to lessen both applicant and reviewer workload by reducing the number of applications needed to secure both operating and infrastructure support; to create a unique, user-friendly funding tool for researchers and institutions; and to ensure an accurate and fair review of both operating and infrastructure support requests. It is expected that this initiative will allow universities and researchers the opportunity to create streamlined, competitive packages for the funding of infrastructure needs and operational research support.
Additional Information:
- Operating grant requests will be governed by the policies and guidelines for CIHR's Operating Grant Program, as described within the text of this priority announcement.
- Infrastructure requests will be governed by CFI's application deadlines, eligibility, notification dates and grant start dates please refer to the CFI's program guide.
- Applications receiving a rating of less than 3.5 will not be considered for funding.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
8. Musculoskeletal Health, Arthritis, Skin and Oral Health. The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant3 to the research priority areas described below:
- Research priorities of CIHR-IMHA
More information on the strategic research priorities of CIHR-IMHA can be found on their website.
The maximum amount awarded for a single grant is up to $100,000 per annum for one year. CIHR-IMHA anticipates that four grants will be funded through this competition.
Additional Information:
- At least half of the grants will be allocated to new investigators4. Any additional funding will be allocated to the next top ranked new investigator first, then the next top ranked established investigator.
- Nominated Principal Investigators are eligible to receive only one grant at a time through IMHA's priority announcement program.
- Applicants must indicate IMHA as the primary institute and fill out a priority announcement relevancy form.
- Researchers who hold a CIHR Open operating grant as a Nominated Principal Investigator at the time of submission to this program are not eligible for funding a priority announcement.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
9. Neuromuscular Research (Neuromuscular Partnership Program). The Institute of Genetics, Institute of Musculoskletal Health and Arthritism, Institute of Neurosciences, Mental Health and Addiction and CIHR in partnership with the Amyotrophic Lateral Sclerosis Society of Canada and Muscular Dystrophy of Canada will fund applications that are determined to be relevant to the research priority areas described below:
- Amyotrophic lateral sclerosis
- Spinal muscular atrophies
- Diseases of the neuromuscular junction
- Muscular Dystrophies (e.g. Duchenne, Becker)
- Inflammatory myopathies
- Myotonia
- Metabolic or endocrine diseases of the muscle
- Congenital myopathies
- Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)*
- Other neuromuscular disorders
(Updated: 2008-01-15)
* Muscular Dystrophy Canada has earmarked an additional contribution of $200,000 for research related to autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). Relevant applications that score above 3.7 will be eligible to receive these funds.
The following broad categories of research are eligible for funding:
- Basic research involving muscle or nerve biology relevant to neuromuscular disease.
- Focused research directed toward an understanding of neuromuscular disease.
- Applied research encompassing research designed specifically to translate promising research advances from basic research and focused research into pre-clinical and clinical investigations relevant to treatment of neuromuscular disease, but not including drug trials.
Equipment may not be funded under this partnership. The decision will be made in alignment with the open competition decisions.
The duration of projects can be for up to (5) years for applications rated above CIHR's funding cut-off and up to (3) three years for applications rated below CIHR's funding cut-off but above 3.7. There is no maximum for a single grant per annum. CIHR anticipates that six to twelve grants will be funded through this competition.
Applications receiving a score of less than 3.7 in the open competition will not be considered for funding.
Additional Information:
- Partner will not pay for parental leave but agrees to extend the term of the grant by the duration of the leave
- For grants funded through this program, progress and end of grant reports will be shared with funding partners. (Updated: 2008-01-15)
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
10. Obesity and Healthy Body Weight. The CIHR Institute of Nutrition, Metabolism and Diabetes will fund applications that are determined to be relevant5 to the prevention and treatment of obesity as described in the Strategic Initiative Excellence, Innovation and Advancement in the Study of Obesity and Healthy Body Weight, as described below:
- Prevention and treatment of obesity
Applicants submitting proposals under the strategic initiative can come from any discipline or area of expertise, and can propose research in any number of areas. Applicants must justify how their application contributes to increasing knowledge to prevent or to treat of obesity.
The maximum amount awarded for a single grant is up to $120,000 per annum for up to three years.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
11. Official Language Minority Communities. The CIHR Research Initiative on Official Language Minority Communities (OLMC) will fund applications that are determined to be relevant to the research priority areas described below:
- Determinants of health6
- Health service governance, management and delivery7
- Language, culture and health8
The maximum amount awarded for a single grant is up to $100,000 per annum for up to three years.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
12. Pandemic Preparedness.
The objective of this priority announcement is to further strengthen the knowledge base and enhance research capacity in pandemic preparedness research by funding three-year operating grants to address questions of influenza transmission, the effectiveness of public health control measures and the fostering of compliance with public health control measures. It is expected that this targeted investment will lead to increased knowledge; the identification of effective public health control measures for responding to an influenza pandemic and controlling disease spread; and the identification of effective strategies for improving compliance with such measures. More information on the research priorities of the Pandemic Preparedness Strategic Research Initiative can be found on the Institute of Infection and Immunity website.
The CIHR Institute of Infection and Immunity in collaboration with the Public Health Agency of Canada (PHAC) will fund applications that are determined to be relevant to the research priority areas described below:
- Effectiveness of targeted public health control measures
Disease avoidance, immunization programs and the provision of anti-virals will play an important role in decreasing the risk of infection during both inter-pandemic and pandemic periods. Research is required into: 1) the value of school closures, home 'isolation' of sick individuals, quarantine of contacts and other means of increasing social distancing; 2) the impact of immunization of health care workers on influenza transmission in health care settings; and 3) the utility of anti-virals as a preventive tool in high-risk populations (e.g., residents of long-term care facilities), in recently exposed susceptible people, in outbreak management and in curbing community spread.
- The role of children in influenza transmission and control
In order to implement effective public health control measures, relevant to both inter-pandemic and pandemic periods, research is needed into the role of children in the spread of the influenza virus within families and communities. If children are an important factor, research is also needed on the following targeted control measures to prevent influenza spread: 1) the value of children wearing masks; 2) the value of implementing measures such as hand hygiene at school; and 3) the impact of immunization of school children on influenza transmission in other age groups.
- Fostering compliance with public health control measures
In order to ensure the effectiveness of public health control measures, social and behavioural research on how populations react to community infection control measures and on how to foster compliance with official recommendations through the use of risk and crisis communication strategies is required. Research is also required to assess the compliance of health care workers with public health control measures specific to health care settings.
More information on the research priorities of CIHR-III, the Pandemic Preparedness Strategic Research Initiative and the Public Health Agency of Canada (PHAC) can be found on their website.
CIHR and PHAC anticipate funding one grant in each of the three relevant research area described above. The maximum amount awarded per grant will be $300,000 per annum for up to three years including the cost of equipment.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
13. Parkinson (Parkinson Society Canada/CIHR-INMHA Research Grant). The CIHR and the Parkinson Society of Canada9 will fund applications that are determined to be relevant to the research priority areas described below:
- Psychosocial research in Parkinson's Disease
The objectives of this priority announcement are to increase interest in and encourage researchers specifically in the area of psychosocial research in Parkinson's disease (PD).
Emphasis is placed on research directed towards closing the gap in understanding and treating non-motor symptoms of Parkinson's and may involve qualitative and /or quantitative methodologies. The inclusion of the end user in some component of the research program is a requirement for consideration of the project and must be specified.
The following psychosocial research topics have been identified as priority issues by Parkinson's Society Canada;
- Investigating the Psychological Well Being of PLWP, Partners and Families,
- Evaluating the Benefits of Standardized care,
- Assessing Medical Services
- The Economic Burden of Parkinson's.
Areas of interest in psychosocial research include but are not limited to:
- Research in the area of concurrency of psychiatric disorders including depression and drug/alcohol abuse amongst PLWP. Research can also focus on the psychological impact of PD on the spouse and family members, as well as individuals who live alone.
- Research that identifies best practice by focusing on the diagnosis and early treatment experiences of PLWP.
- Projects that focus on methods of improving support and access to services for people living with Parkinson's disease (PLWP). Groups include but are not limited to more advanced level PD caregivers, young onset and/or newly diagnosed individuals, individuals who live in rural area.
- Projects that focus on methods for improving appropriate services for PLWP from ethnic communities incorporating accommodation of language and cultural barriers.
- Research directed to exploring the economic burden of PD on PLWP and their families. Research should include, but is not limited to, loss of income, cost of treatments, and comparison of impact on young versus older onset patients.
This grant may be awarded to an individual researcher; however, submissions from teams of researchers that reflect multi-disciplinary approaches and /or inter-regional collaboration are also strongly encouraged. Applications receiving a rating of less than 3.5 will not be considered for funding.
More information on the research priorities of Parkinson Society of Canada can be found on their website.
The maximum amount awarded for a single grant is up to $50,000 per annum for two years. CIHR anticipates that one grant will be funded through this competition.
Additional Information:
- Partner will not pay for parental leave but agrees to extend the term of the grant by the duration of the leave
- The grant is non-renewable
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
14. Regional Partnerships Program - Manitoba (RPP-Man). CIHR, through the Regional Partnerships Program (RPP), in partnership with Manitoba Health Research Council may fund applications in Manitoba in all four pillars of research, subject to funding availability.
The maximum amount awarded for a single grant is $100,000/year for up to 2 years except where $100,000 is not equivalent to 75% or greater of the approved annual budget of an individual grant, then 75% pro-rated budget amount will apply. Approximately 6 grants are expected to be funded (subject to the availability of funds).
Please note researchers must submit their applications at least two weeks prior to the CIHR deadline to have their applications vetted by the internal review procedures at MHRC in order for their grant to be eligible for consideration for RPP funding.
Additional Information:
- The grant is not renewable through the RPP program
- Recipient will be the top ranked researcher
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
15. Regional Partnerships Program - New Brunswick (RPP-NB). CIHR, through the Regional Partnerships Program (RPP) in partnership with New Brunswick-RPP may fund applications in all four pillars of health research that contribute to the goal of building health research capacity in New Brunswick, which meet RPP eligibility requirements.
More information on the research priorities of New Brunswick can be found on their website.
The maximum amount awarded for a single grant is $100,000 per annum for up to 3 years. Approximately 3 grants are expected to be funded (pending availability of funds).
Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures of the New Brunswick RPP Advisory Board a minimum of two weeks prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding.
Additional Information:
- The grant is not renewable through the RPP program
- Recipient will be the top ranked researcher
- The grant must be held in New Brunswick and in accordance with the CIHR-RPP guidelines
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
16. Regional Partnerships Program - Newfoundland and Labrador (RPP-NL). CIHR, through the Regional Partnerships Program (RPP), in partnership with Newfoundland and Labrador-RPP may fund applications in all four pillars of health research in NL which meet RPP eligibility requirements.
More information on the research priorities of Newfoundland and Labrador can be found on their website.
The maximum amount awarded for a single grant is $150,000 per annum for up to three years for new grants, and one year for renewals. Approximately 6 grants are expected to be funded (pending availability of funds).
Please note researchers must submit their applications at least one month prior to the CIHR deadline to have their applications vetted by the internal review procedures at RPP-NL in order for their grant to be eligible for consideration for RPP funding. Contact for this process is:
Office of Research and Graduate Studies,
Faculty of Medicine
Memorial University
St. John's NL
Additional Information:
- The grant is non-renewable under the RPP prgram
- The grant must be held in NL and in accordance with the CIHR-RPP guidelines.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information" For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
17. Regional Partnerships Program - Nova Scotia (RPP-NS). CIHR, through the Regional Partnerships Program (RPP), in partnership with the Nova Scotia Health Research Foundation may fund applications in all four pillars of health research in Nova Scotia pending funding availability, which meet RPP eligibility requirements.
New grants are awarded for up to three years. The maximum amount awarded for a renewal grant is $70,000 for one year. Approximately 4 to 8 grants (new and renewal) are expected to be funded (pending availability of funds).
Please note that in order to be considered for RPP funding, researchers must submit their applications to NSHRF within 10 business days of the CIHR deadline in order for their grant to be eligible for consideration for RPP funding.
Additional Information:
- The grant is non-renewable under the RPP program
- The grant must be held in Nova Scotia and in accordance with the CIHR-RPP guidelines
- Recipient will be the top ranked researcher
For questions about this research initiative and research objectives, see Appendix 1, under "More Information" For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
18. Regional Partnerships Program - Prince Edward Island (RPP-PEI). CIHR, through the Regional Partnerships Program(RPP), in partnership with Prince Edward Island-RPP may fund applications that span the four pillars of research that contribute to the goal of building health research capacity in PEI. The following areas of research strength at UPEI reflect these four pillars:
- Cardiovascular and respiratory health research
- Metabolism, nutrition and diabetes
- Human development and cognition
- Cancer research
- Applied health services and health promotion
- Natural products and human health
- Population health.
More information on the research priorities of Prince Edward Island can be found at in the University of Prince Edward Island Strategic Plan [ PDF | Help ].
The maximum amount awarded for a single grant is up to $100,000 per annum for up to 3 years. However, the amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available. Approximately 2 grants are expected to be funded (pending availability of funds).
Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures at the PEI Health Research Institute a minimum of two months prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding.
Additional Information:
- The grant is non-renewable under the RPP program
- The grant must be held in Prince Edward Island
- Recipient will be the top ranked researcher
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
19. Regional Partnerships Program - Saskatchewan (RPP-SK). CIHR, through the Regional Partnerships Program (RPP) in partnership with Saskatchewan-RPP may fund highly rated applications in Saskatchewan, subject to funding availability.
Operating grants from all four pillars of research will be supported based upon the ratings that they received. However, 50% of the available funding will be awarded based upon the following listed research priority areas:
- Health needs of Aboriginal people and Seniors;
- Health systems and policy research, with emphasis on: health human resources and workforce planning; quality management and improvement; primary health care; mental health and addictions; innovative delivery models; and rural and remote health services;
- Determinants of health status, including early childhood development and the prevention and underlying causes of chronic and lifestyle-related disease (particularly diabetes, obesity and smoking);
- Public health including infectious diseases and water and food safety; and
- Synchrotron-based health research.
More information on the Saskatchewan priorities can be found in the Health Research Strategy.
The grant amount will be as recommended by CIHR; the duration will be for two years, unless a shorter period is recommended by CIHR.
Please note that researchers must have their CIHR applications vetted by the internal review procedures at their University or institution prior to submitting to CIHR in order for their grant to be eligible for consideration for RPP funding: University of Saskatchewan - 6 weeks prior to CIHR deadline, University of Regina- 4 weeks prior to CIHR deadline. Please contact the Research Offices at the University of Saskatchewan and the University of Regina for more information
To be considered for the Saskatchewan priority areas (see above), researchers must provide a copy of the summary page of their application and a one-page statement justifying the fit of the application with at least one priority area. These should be submitted to the Chair of the Saskatchewan-CIHR RPP Advisory Committee by April 30.
Submissions can be by email: dawn.sinclair@usask.ca or by mail:
Office of the Associate Vice-President Research (Health),
B527 Health Sciences Building,
University of Saskatchewan,
107 Wiggins Road,
Saskatoon, SK,
S7n 5e5
Additional Information:
- The grant is non-renewable for the first re-application following RPP funding
- The grant must be held in a Saskatchewan institution by a Saskatchewan researcher; for eligibility guidelines, see the Saskatchewan - CIHR RPP Policies.
- Recipient will be the top ranked researchers after consideration of the requirements above.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
20. Reproductive and Child Health (Start-Up Grants for New Investigators). The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH) will fund applications that are determined to be relevant to the research priority areas, as indicated below:
The objective of this priority announcement is to further strengthen research that relates to the Strategic Research Priorities of the CIHR-IHDCYH by increasing research capacity. It is expected that this targeted investment will lead to increased success rates for new Principal Investigators in future CIHR regular open competitions.
The maximum amount awarded for a single grant is $100,000 per annum for up to one year. CIHR-IHDCYH anticipates that approximately three grants will be funded through this competition.
Additional Requirement:
- Grants are offered only to investigators with less than six years of experience as independent investigators since their first academic appointment (i.e. after March 2002, including experience outside Canada) and who have never held a CIHR grant as a Principal Investigator (including the SickKids Foundation (SKF)/IHDCYH New Investigators Grants Program).
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
21. Transfusion related acute lung injury (TRALI). The CIHR Institute of Circulatory and Respiratory Health in partnership with the Canadian Blood Services (CBS) will fund applications that are determined to be relevant to the research priority areas described below:
- Transfusion related acute lung injury (TRALI)
Research projects may focus on any relevant research question within biomedical, clinical, or health policy research. Examples of relevant questions include defining the scope of TRALI, mechanisms of induction of TRALI in both animals models and patient populations, identification of pathogenic antibodies, identification of best testing methods, studies to inform donor deferral policy making, identification of factors (including genetic factors) that increase a recipient's susceptibility to TRALI, and epidemiology studies to establish the incidence of TRALI.
More information on the research priorities of CIHR-ICRH and the Canadian Blood Services (CBS) can be found on their websites.
Additional Information:
- Partner will not pay for parental leave but agrees to extend the term of the grant by the duration of the leave
- The grant is non-renewable
For questions about this research initiative and research objectives, see Appendix 1, under "More
Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
B. Research Related to CIHR Institute Mandates:
The following CIHR Institutes are offering priority announcements for research related to their mandates. The maximum amount awarded for a single grant is $100,000 per annum for up to one year.
22. CIHR Institute of Cancer Research (Bridge Funding).
For questions about this research initiative and research objectives, see Appendix 1, under "More Information" For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
23. CIHR Institute of Circulatory and Respiratory Health.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
24. CIHR Institute of Genetics (CIHR-IG) (Bridge Funding: Primary and Secondary Suggested CIHR Institute).
The objective of the CIHR Institute of Genetics One-Year Bridging Operating Grants is to ensure the maintenance of excellent research programs. These one-year operating grants afford principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees. Applications receiving a rating of less than 4.0 will not be considered for funding.
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
25. CIHR Institute of Infection and Immunity (Bridge Funding)
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
26. CIHR Institute of Neuroscience, Mental Health and Addiction (Bridge Funding)
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
27. CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD) (Bridge Funding).
For questions about this research initiative and research objectives, see Appendix 1, under "More Information". For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
Top
Eligibility
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Eligibility requirements specific to the Operating Grant Program include the following:
- Only applicants who meet the definition of Principal Applicant, as described in the CIHR Grants and Awards Guide, may submit an application to the Operating Grant Program.
- There is no limit to the number of applications an applicant can submit as a Principal Applicant, whether he/she is the Nominated Principal Applicant or a Co-Principal Applicant, to each Operating Grant competition.
- Applicants to the Operating Grant Program may request that their application be considered for:
- Up to three Priority Announcements per application, in each Operating Grant competition;
- Any number of additional Priority Announcements for research related to a CIHR Institute’s mandate, Linked Programs, for example, the Regional Partnerships Program, the Neuromuscular Research Program (Spring competitions only), and the CIHR-Arthritis Society Partnership Program.
Randomized controlled trials are not funded through this program. For applications including randomized controlled trials, researchers must apply through the Randomized Controlled Trials Program: 2007-2008 and not through the Operating Grant Program.
Top
Guidelines
Applications funded through the Operating Grant Program are subject to funding policies outlined in the CIHR Grants and Awards Guide. Guidelines governing CIHR’s grant programs are outlined in Section 3: General Guidelines for Grant Programs. Applicants are encouraged to demonstrate the use of Gender and Sex-Based Analysis in applications.
Allowable Costs
Applicants should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Financial Administration Guide for a complete listing and description of allowable costs and activities.
The full application must provide a detailed justification of all costs.
Conditions of Funding
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through the Operating Grant Program. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official Languages Policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR’s Support. Successful applicants will be informed of any special financial requirements prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR’s premises including, without limitation, cost-sharing agreements related to this funding opportunity and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Funding opportunity will be collected, used and disclosed in compliance with the PIPEDA.
Communication Requirements
Grant recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Public Communication and Acknowledgement of CIHR's Support for details on CIHR’s communication requirements. The contributing institutes / partners will be identified on the Authorization for Funding and decision letter.
Top
Performance Measurement
CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
- adhere to CIHR’s reporting requirements and provide required information in a timely fashion. A Progress Report for Long-Term Grant Holders (5 or more years) will be required in year 3 of grants of duration of 5 years or more. Grantees are required to submit the Progress Report for Long-Term Grant Holders (5 or more years) describing the progress made and the publications issued since the start of the grant. CIHR will cancel the last 12 months of the grant if the progress is unacceptable and will cancel the final two years of the grant if it does not receive a report. The "Progress Report for Long-Term Grant Holders (5 or more years)" can be found under List of Forms and Guidelines for Completion;
- contribute to the monitoring, review and evaluation of CIHR’s programs, policies and processes by participating in evaluation studies, surveys, workshops, audits and providing data or reports as required for the purpose of collecting information to assess progress and results;
- encourage their associates, trainees and administration to participate in the monitoring, review and evaluation of CIHR’s programs, policies and processes as required.
Top
Review Process and Evaluation
Relevance Review
A. CIHR Research Priority Areas:
CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described under "CIHR Research Priority Areas" within the "Objectives" section.
Relevance of the applications to the research priorities will be determined in the following manner.
Prior to peer review, CIHR and the partner organizations will review applications to determine the relevance, or alignment, of the research proposed to the research priority area(s) described above.
To conduct relevance review, these representatives will have access to a completed relevance form in addition to anonymized project titles and summaries, provided that applicants have consented to the sharing of information in consideration for other funding opportunities as well as to the sharing of information to observers in completing their ResearchNet application.
Upon completion of peer review, the CIHR and the partner organizations will receive the ratings, rankings and peer review committee recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the specific objectives of the research initiative and the research priority areas described under "CIHR Research Priority Areas"; and 2) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted. These applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a ranking below 3.5 will not be funded.
Peer review committees will not be informed of applications submitted for funding through this announcement.
B. Research Related to CIHR Institute Mandates:
Upon completion of peer review, representatives of each CIHR Institute will receive a randomized list of applications for which the Institute was selected as primary (and where indicated, secondary) Institute under "Suggested Institutes" on the "Project Descriptors" page of the ResearchNet application. The randomized list will include anonymized titles, project summaries and peer review committee recommendations on funding levels. Eligible applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a rating below 3.5 will not be funded.
Peer review committees will not be informed of applications submitted for funding through this announcement.
Peer Review
A CIHR peer review committee will evaluate the full applications. Committee members are selected following CIHR’s Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). For information on CIHR’s peer review process in general, see the Peer Review section of CIHR’s website.
Evaluation Criteria
Peer review will be conducted in accordance with The CIHR Peer Review Process - Policies and Responsibilities of Grants Committee Members, including the standard evaluation criteria described under "Factors in the Assessment" (section 6.2).
Applications to the CIHR Operating Grant Program are reviewed by one of approximately 50 peer review committees specifically constituted to support the CIHR Operating Grant Program. Each committee consists of about 10-16 members, including a Chairperson and Scientific Officer. For a list of these committees and their respective mandates, refer to Peer Review Committees and Mandates on the CIHR website.
Top
How to Apply
Applications are submitted through the March 2008 (2008-03) competition of the CIHR Operating Grant: 2007-2008 funding opportunity. The application instructions are outlined in the "How to Apply" section of the Operating Grant: 2007-2008 funding opportunity.
Please note that all applicants to the Operating Grant: 2007-2008 funding opportunity are required to submit their Registrations and Full Applications electronically using ResearchNet.
Additional Instructions
A. CIHR Research Priority Areas:
Priority announcements for research in specific CIHR priority areas are listed in the "Objectives" section of this funding opportunity, under "CIHR Research Priority Areas."
To apply for funding through these priority announcements, select the priority announcement title and relevant research area(s) addressed by your research proposal in the "Identify Priority Announcements and Relevant Research Area" section of your ResearchNet application.
You may request that your application be considered for up to three priority announcement research areas per application, in each Operating Grant competition.
B. Research Related to CIHR Institute Mandates:
Priority announcements for research related to CIHR Institute mandates (including bridge funding priority announcements) are listed in the "Objectives" section of this funding opportunity, under "Research Related to CIHR Institute Mandates."
When you select a CIHR Institute as a primary (and where indicated, secondary) Institute under "Suggested Institutes" on the "Project Descriptors" page of your ResearchNet application, the Institute will automatically consider your application for funding through the priority announcement process whenever it offers a priority announcement for research related to its mandate. Consideration for funding through CIHR Institute mandate priority announcements is in addition to consideration for priority announcement funding in specific research priority areas.
Top
Contact Information
1. For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
CIHR Info Desk Service
Canadian Institutes of Health Research
Telephone: 613-954-1968
Toll-free: 1-888-603-4178
Email: info@cihr-irsc.gc.ca
Specific information about the Operating Grant Program peer review committees can also be obtained by contacting the individuals listed on the CIHR Committees and Programs Contacts page of the CIHR website.
2. If you are experiencing technical difficulties with your ResearchNet account or the e-Submission process contact:
CIHR ResearchNet Support
Canadian Institutes of Health Research
Telephone: 613-941-9080
Email: support@researchnet-recherchenet.ca
3. For questions about specific priority announcements and their research objectives, see Appendix 1, under More Information.
Top
Partner/Collaborator Description
N/A
Top
Additional Information
Appendix 1: Contacts for questions about specific priority announcements and their research objectives.
1. Aging
For questions about this initiative and research objectives contact:
Sharon Nadeau, Associate, Strategic Initiatives, CIHR-IA
Telephone: 613-946-1270
Fax: 613-954-1800
Email: snadeau@cihr-irsc.gc.ca
2. Blood Supply Risk
For questions about this initiative and research objectives contact:
Katherine Gardner, Project Officer, CIHR-ICRH
Telephone: 613-941-0086
Fax: 613-954-1800
E-mail: kgardner@cihr-irsc.gc.ca
3. Blood Utilization and Conservation
For questions about this initiative and research objectives contact:
Katherine Gardner, Project Officer, CIHR-ICRH
Telephone: 613-941-0086
Fax: 613-954-1800
E-mail: kgardner@cihr-irsc.gc.ca
4. Ethics
For questions about this initiative and research objectives contact:
Lynne Cayer, Ethics Office, CIHR
Telephone: 613-952-4264
Fax: 613-954-1800
Email: lcayer@cihr-irsc.gc.ca
5. History of Medicine
For questions about this initiative and research objectives contact:
Julie Calendino, Program Delivery Officer, CIHR (Updated: 2008-02-19)
Telephone: 613-941-0861
Fax: 613-954-1800
Email: jcalendino@cihr-irsc.gc.ca
6. HIV/AIDS
For questions about this initiative and research objectives contact:
Jennifer Ralph, Program Officer, HIV/AIDS Research Initiative
Telephone: 613-941-4464
Fax: 613-954-1800
Email: jralph@cihr-irsc.gc.ca
7. Infrastructure and Operating Grants (Leaders Opportunity Fund)
For questions related to specific CFI competitions and programs, including CFI funding guidelines and how to apply contact:
Mark Lagacé, Manager, Leaders Opportunity Fund
Canada Foundation for Innovation
Telephone: 613-996-3107
Fax: 613-943-0923
Email: mark.lagace@innovation.ca
8. Musculoskeletal Health, Arthritis, Skin and Oral Health
For questions about this initiative and research objectives contact:
Todd Lavictoire
Institute of Musculoskeletal Health and Arthritis
Canadian Institutes of Health Research
Telephone: 613-957-8678
Fax.: 613-954-1800
E-mail: tlavictoire@cihr-irsc.gc.ca
9. Neuromuscular Research (Neuromuscular Partnership Program)
MDC
Marla Spiegel, Director of Research, Education and Advocacy
Suite 900-2345 Yonge Street
Toronto, ON, M4P 2E5
Telephone: 416-488-0030 ext. 134
Fax: 416-488-7523
Email: marla.spiegel@muscle.ca
ALS Society of Canada
Denise Figlewicz, Director of Research
265 Yorkland Boulevard, Suite 300,
Toronto, Ontario, M2J 1S5
Telephone: 416-497-2267 x 202
Fax: 416-497-1256
Email: daf@als.ca
IG
Stephanie Robertson, Assistant Director, Ottawa
160 Elgin Street
Ottawa, Ontario, K1A 0W9
Telephone: 613-954-0533
Fax: 613-954-1800
Email: srobertson@cihr-irsc.gc.ca
IMHA
Louise Desjardins, Assistant Scientific Director
160 Elgin Street
Ottawa, Ontario, K1A 0W9
Telephone: 613-851-5246
Fax: 613-841-2614
Email: ldesjardins@cihr-irsc.gc.ca
INMHA
Barbara Beckett, Assistant Director, Ottawa
160 Elgin Street, Ottawa, K1A 0W9
Telephone: 613-948-4877
Fax: 613-954-1800
Email: bbeckett@cihr-irsc.gc.ca
10. Obesity and Healthy Body Weight
For questions about this initiative and research objectives contact:
Paul Bélanger, Assistant Director - Ottawa, CIHR-INMD
Telephone: 613-941-6465
Fax: 613-954-1800
Email: pbelanger@cihr-irsc.gc.ca
11. Official Language Minority Communities
For questions about this initiative and research objectives contact:
Johanne Lapointe, Team Lead, Research Initiatives, CIHR
Telephone: 613-954-2474
Fax: 613-954-1800
Email: jlapointe@cihr-irsc.gc.ca
12. Pandemic Preparedness
For questions about this initiative and research objectives contact:
Carol Richardson, Manager, Programs and Evaluation, CIHR Institute of Infection and Immunity
Telephone: 519-661-3228
Fax: 519-661-4226
Email: carol.richardson@schulich.uwo.ca
Anne Malo, Head, Research, Immunization and Respiratory Infections Division, Public Health Agency of Canada
Telephone: 613-952-9156
Fax: 613-946-0244
Email: anne_malo@phac-aspc.gc.ca
13. Parkinson
For questions about this initiative and research objectives contact:
Ivy Lim-Carter , Manager, National Research & Clinical Programs, Parkinson Society Canada
Telephone: 416-227-3382 (direct line)
Fax: 416-227-9600
E-mail: ivy.lim-carter@parkinson.ca
14. Regional Partnerships Program - Manitoba (RPP-Man)
For additional information on eligibility criteria and funding details, please contact:
Liz Ford, Administration Officer, Manitoba Health Research Council
Telephone: 204-775-1096
Fax: 204-786-5401
Email: info@mhrc.mb.ca
Website: www.mhrc.mb.ca
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
April Amponsah, Program Delivery Coordinator, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON
K1A 0W9
Telephone: 613-948-8201
For questions about this initiative and research objectives contact:
Erik Blache, Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: eblache@cihr-irsc.gc.ca
15. Regional Partnerships Program - New Brunswick (RPP-NB)
For questions about the NB RPP Advisory Board review process and criteria, please contact:
John Boyne, Administrator, Medical Research Fund of New Brunswick
P.O. Box 5100
520 King Street, Fredericton, N.B
E3B 5G8
Telephone: 506 444-3222
Fax: 506 453-2958
Email: john.boyne@gnb.ca
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
April Amponsah, Program Delivery Coordinator, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON
K1A 0W9
Telephone: 613-948-8201
For questions about this initiative and research objectives contact:
Erik Blache, Senior Advisor, Partnerships and Citizen Engagement,
Canadian Institutes of Health Research
Telephone.: 613-948-2684
Fax: 613-954-1800
E-mail: eblache@cihr.gc.ca
16. Regional Partnerships Program - Newfoundland and Labrador (RPP-NL)
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
April Amponsah, Program Delivery Coordinator, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON
K1A 0W9
Telephone: 613-948-8201
For questions about this initiative and research objectives contact:
Erik Blache, Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: eblache@cihr-irsc.gc.ca
17. Regional Partnerships Program - Nova Scotia (RPP - NS)
Contact for this program is:
Catherine Connors, Manager,
Health Research & Matching Grants Programs,
Nova Scotia Health Research Foundation
Telephone: 902-424-3370
Fax: 902-424-7753
E-mail: connorcn@gov.ns.ca
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
April Amponsah, Program Delivery Coordinator, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON
K1A 0W9
Telephone: 613-948-8201
For questions about this initiative and research objectives contact:
Erik Blache, Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: eblache@cihr-irsc.gc.ca
18. Regional Partnerships Program - Prince Edward Island (RPP-PEI)
Please contact the following for additional information:
Donna Murnaghan , Associate Director, PEI Health Research Institute
University of Prince Edward Island
550 University Avenue
Charlottetown, Prince Edward Island
C1A 4P3
Telephone: 902-894-2812
E-mail: Dmurnaghan@upei.ca
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
April Amponsah, Program Delivery Coordinator, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON
K1A 0W9
Telephone: 613-948-8201
For questions about this initiative and research objectives contact:
Erik Blache, , Senior Advisor, , Partnerships and Citizen Engagement,
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
E-mail: eblache@cihr.gc.ca
19. Regional Partnerships Program - Saskatchewan (RPP-SK)
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
April Amponsah, Program Delivery Coordinator, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON
K1A 0W9
Telephone: 613-948-8201
For questions about this initiative and research objectives contact:
Erik Blache, Senior Advisor, Partnerships and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
Email: eblache@cihr-irsc.gc.ca
20. Reproductive and Child Health (Start-Up Grants)
For questions about the objectives and relevant research areas:
Anne-Cécile Desfaits, PhD, Assistant Director, CIHR-IHDCYH
Telephone: 514-412-4414
Fax: 514-412-4253
Email: adesfaits@cihr-irsc.gc.ca
21. Transfusion related acute lung injury (TRALI)
For questions about this initiative and research objectives contact:
Katherine Gardner, Project Officer, CIHR-ICRH
Telephone: 613-941-0086
Fax: 613-954-1800
E-mail: kgardner@cihr-irsc.gc.ca
22. CIHR Institute of Cancer Research (CIHR-ICR) (Bridge Funding)
For questions about this initiative and the mandate of CIHR-ICR contact:
Benoît Lussier, Assistant Director, CIHR-ICR
Telephone: 514-398-4964
Fax: 514-398-8845
Email: benoit.lussier@mcgill.ca
23. Institute of Circulatory and Respiratory Health (Bridge-Funding)
For questions about this initiative and research objectives contact:
Katherine Gardner, Project Officer, CIHR-ICRH
Telephone: 613-941-0086
Fax: 613-954-1800
E-mail: kgardner@cihr-irsc.gc.ca
24. Institute of Genetics (Bridge-Funding)
For questions about this initiative and the mandate of CIHR-IG contact:
Stephanie Robertson, Assistant Director, CIHR-IG
Telephone: 613-954-0533
Fax: 613-954-1800
Email: srobertson@cihr-irsc.gc.ca
25. Institute of Infection and Immunity (Bridge Funding)
For questions about this initiative and the mandate of CIHR-III contact:
Carol Richardson, Manager - Programs and Evaluation, CIHR-III
Telephone: 519-661-3228
Fax: 519-661-4226
Email: carol.richardson@schulich.uwo.ca
26 .Institute of Neuroscience, Mental Health and Addiction (Bridge Funding)
For questions about this initiative and the mandate of CIHR-INMHA contact:
Richard Brière, Assistant Director, CIHR-INMHA
Telephone: 514-761-6131, ext. 3930
Fax: 514-888-4060
Email: richard.briere@douglas.mcgill.ca
27. Institute of Nutrition, Metabolism and Diabetes (Bridge Funding)
For questions about this initiative and the mandate of CIHR-INMD contact:
Paul Bélanger, Assistant Director - Ottawa, CIHR-INMD
Telephone: 613-941-6465
Fax: 613-954-1800
Email: pbelanger@cihr-irsc.gc.ca
- Infrastructure and Operating Grants (Leaders Opportunity Fund). The Canada Foundation for Innovation (CFI) is an independent corporation created by the Government of Canada to fund research infrastructure. The CFI's mandate is to strengthen the capacity of Canadian universities, colleges, research hospitals, and non-profit research institutions to carry out world-class research and technology development that benefits Canadians.
- Infrastructure and Operating Grants (Leaders Opportunity Fund). The following criteria will be used in conducting the review of the CFI infrastructure request:
- Quality of the research and need for the infrastructure
- Contribution to strengthening the capacity for innovation
- Potential benefits to Canada
- Musculoskeletal Health, Arthritis, Skin and Oral Health. The extent to which the relevance form addresses at least one of CIHR-IMHA's three research priorities listed above. A Yes/No score is given.
- Musculoskeletal Health, Arthritis, Skin and Oral Health. A new investigator is defined as a researcher who has completed all formal training, but with 5 years or less experience as an independent investigator. One does NOT need a new investigator salary award to be classified as a new investigator.
- Obesity and Healthy Body Weight. The following criteria will be used in conducting the relevance review:
- Increase understanding of, prevention and treatment of obesity or maintenance of healthy body weight.
- Does the proposed investigation pertain directly to obesity/healthy body weights and is it relevant to a broader population or greater burden of disease, disability or health risk?
- Official Language Minority Communities. Determinants of Health: This research area seeks to identify the bio-psycho-social determinants of health and the health needs of official language minority populations, document the access these populations have to health services and determine how accessibility affects their health.
Population health research looks at all determinants of health: the social and physical environment in which populations live, resources available to them, health services, lifestyle, cultural practices and biological determinants. This view incorporates two major factors that may explain health inequalities: the personal factor, which explores the characteristics of individuals, and the contextual factor, which looks at living environments (resources and infrastructures) and the collective functioning (sociocultural and historical characteristics of the community, degree of integration, mobility, norms and values).
- Official Language Minority Communities. Health service governance, management and delivery: The issue of health institution governance by official language minorities is still not clearly documented. The community argument is only at the early stages, and research on this subject is therefore delayed. As such, it is important to reinforce knowledge to gain a better understanding of minority community governance regarding health in Canada. It is also important to identify the political and administrative issues raised by jurisprudence and institutional duality and better grasp the new health-related observations. Issues relating to greater participation by official language minority communities in governance bodies and decision-making guide this branch of research. The concerns of official language minorities surrounding health service delivery in both official languages and the management of this service suggest that governance of health care institutions is undergoing far-reaching changes that must be better documented.
- Official Language Minority Communities. Language, culture and health: The connections between language, culture and health have to do with the effects of the minority linguistic and cultural experience on identity development and health. For example, this has an impact on access to health promotion and prevention services and to primary and specialized health care. This also comes into play with communication between people receiving health care and health workers. It is also important to understand the processes of linguistic assimilation and acculturation, which may affect the self-esteem and identity development of people in minority communities.
The connections between "language, culture and health" particularly affect certain "client groups": early childhood, youth, seniors, women, new Canadians, Aboriginal People and people with mental health or psychosocial problems. Speech, verbal and non-verbal communication, the meaning of "symbols" and general comprehension are closely linked to culture and language. When it comes to health problems, it is particularly crucial for people to be able to use their own language to explain their symptoms, state of mind, difficulties and pains to a professional who understands their language. It is important to understand the situation of members of official language minority communities, how they view the limited access to services they encounter and the impact this situation has on their health. With an active immigration policy, the specific situation of new francophones from Africa, Asia and the West Indies is among the shifting issues of access to French-language services. Only research into these issues will improve our knowledge so that we can document the connections between language, culture and health.
- Parkinson. Parkinson Society Canada is committed to advancing our research program to better serve Canadians with Parkinson's, to foster Canadian Parkinson's research leadership internationally, and to support efforts to ease the burden and find a cure.
Parkinson Society Canada is a not for profit, national charitable organization. The Society raises money through corporate sponsorships, public donations, and planned gifts. Finding the cause and cure for Parkinson's disease remains our chief mission. However, while we wait for answers, we must not forget the patients and caregivers. New publications, increased patient conferences, clinical assistance programs, as well as other projects also require your support and funding. While we have come a long way towards raising Parkinson's disease in the consciousness of Canadians, we have more to do.
Top
| 
